23.04.2012 • NewsChina National Offshore Oil CorpCNOOCCNPC

CNPC, PDVSA to Start Building Joint Refinery in Late April

State-run China National Petroleum Corp (CNPC) and Petroleos de Venezuela (PDVSA) will start building their mega joint refinery on China's southern coast later this month, a move would pave the way for more Venezuelan oil to flow to the world's second-largest oil user.

CNPC, which operates key businesses via PetroChina , has been preparing for a formal construction kickoff of the 400,000 barrels-per-day (bpd) Jieyang plant in the coming weekend, two company officials said.

Construction of the plant in the eastern part of Guangdong province could take three to four years, a CNPC planning official said.

Caracas' oil sales to China could almost triple on completion of the refinery, which is designed to process Venezuelan heavy oil.

China's environment watchdog cleared the way for the 57.3 billion yuan ($9.08 billion) refinery in January last year and the State Council, the country's cabinet, was reported by Chinese media to have endorsed the project recently.

CNPC owns 60% of the refinery and PDVSA 40%.

It would be the second major stronghold for CNPC in the south China market after it started up its 200,000-bpd Qinzhou refinery in Guangxi in late 2010.

CNPC is also considering a 400,000-bpd refinery and a 1.2 million ton-per-year ethylene complex in Taizhou in Zhejiang province with partners Qatar Petroleum and Royal Dutch Shell.

China Petrochemical, which operates refineries via China Petroleum and Chemical Corp (Sinopec) , is the leading fuel supplier in south China but its dominance is being eroded by CNPC and China National Offshore Oil Corp (CNOOC).

 

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.